Fundraising FoxFidelity Investments — 2023 Investments
5 investments dated 2023 · listed companies and verified rows first · show all
Agomab is a clinical-stage biopharmaceutical company developing disease-modifying therapies for fibro-inflammatory and fibrotic diseases with high unmet medical need.
BiotechHealthtechMedical DevicesAntwerp, BE
Tim Knotnerus(Chief Executive Officer)in
Co-investorsEQT Life SciencesAdBio partnersAndera PartnersAsabys PartnersCanaan PartnersOmnes Capital+2 more
Aledade is an accountable care organization (ACO) partner that works with primary care organizations to improve patient outcomes and healthcare quality.
Enterprise SoftwareHealthtechBethesda, US
Bijan Salehizadeh(Co-founder)inFarzad Mostashari(Founder)inMat Kendall(Founder)in
BoardRobert Kocher(Director)in
Co-investorsActivate Venture PartnersARCH Venture PartnersEcho Health VenturesGV (Google Ventures)Intrepid Growth PartnersIVP (Institutional Venture Partners)+11 more
Envise provides interactive real estate solutions and property management tools for real estate companies and their customers throughout the property lifecycle.
PropTechSaaS
Anna Nordström(CEO)in
Co-investorsRound2 Capital PartnersGV (Google Ventures)T. Rowe PriceViking Global Investors
Evozyne designs and builds engineered protein therapeutics using an AI-native platform, focusing on treatments for immune-mediated diseases.
AI & Machine LearningBiotechDeep TechHealthtechChicago, US
Aris Theologis(Executive Officer, Director)inDarien Parhad(Executive Officer)Patrick J. Morris(Executive Officer, Director)Marc Yoskowitz(CEO)inRama Ranganathan(Founder)Andrew Ferguson(Founder)
Co-investorsParagon Biosciences LLCIn-Q-TelNVIDIAOrbiMedValor Equity PartnersNVentures
VAST Data builds a global data platform designed to enable AI agents to store, process, and execute tasks.
AI & Machine LearningCloud ComputingData & InfrastructureNew York City, US
Jeff Denworth(Founder)inRenen Hallak(Founder)inAlon Horev(Founder)inShachar Fienblit(Founder)
Co-investors83NorthAccess Ventures (New York)Alpha Square GroupAspire11Bond Capital ManagementCats.vc+19 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.